Private equity house Riverside has announced its purchase of Diatron, a Budapest-based manufacturer of hematology analysers. This deal marks Riverside's 117th leveraged buyout since the firm's founding in 1988.
In order to view premium content you need to be a Premium Subscriber. You can subscribe now to access premium online content.
Become a Premium SubscriberIf you are already a AltAssets subscriber please log in below.